Global X Telemedicine & Digital Health ETF Rating $29.32 +0.33 (+1.14%) As of 09/25/2026 Add Compare Share Share Ratings Stock AnalysisChartHoldingsRatings Global X Telemedicine & Digital Health ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.EDOC Aggregate RatingModerate Buy 2.53Holdings in EDOC have an aggregate rating of Moderate Buy based on 350 analyst ratings issued in the past year covering 19 companies (65.9% of the portfolio).EDOC Aggregate Price Target$29.32High Prediction$29.32Average Prediction$29.32Low Prediction$29.32Holdings in EDOC have an aggregate price target of $29.32 and a range of $29.32 to $29.32 covering 19 companies (65.9% of the portfolio).EDOC Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy0 Buy rating(s)Moderate Buy9 Moderate Buy rating(s)Hold10 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Global X Telemedicine & Digital Health ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 19 EDOC Holdings ExportWeight In ETFCompanyShare PriceConsensus RatingConsensus Price TargetPossible UpsideNumber of RatingsMarketRank™Indicator(s)ViewRatings5.91%TEMTempus AI$85.01+3.4%Hold$69.63 -18.1%221.6309 of 5 starsTrending NewsInsider Trade5.35%HIMSHims & Hers Health$29.46+0.6%Hold$32.43 10.1%162.065 of 5 starsTrending NewsInsider TradeGap Up5.03%IQVIQVIA$270.12-1.8%Moderate Buy$248.00 -8.2%172.6689 of 5 starsAnalyst Upgrade4.79%VEEVVeeva Systems$280.95+2.2%Moderate Buy$284.88 1.4%282.4777 of 5 starsTrending NewsAnalyst Downgrade4.59%PODDInsulet$136.13+0.3%Hold$195.40 43.5%264.0736 of 5 starsPositive News4.36%RMDResMed$222.20+0.1%Hold$241.69 8.8%163.778 of 5 starsPositive News4.21%IRTCiRhythm Technologies$110.38-0.4%Moderate Buy$179.93 63.0%163.5122 of 5 starsNews CoverageAnalyst Upgrade4.11%GEHCGE HealthCare Technologies$66.63+0.4%Moderate Buy$78.39 17.7%224.4989 of 5 starsDividend IncreaseAnalyst Forecast3.85%TMDXTransMedics Group$85.29+1.7%Hold$121.10 42.0%124.5394 of 5 starsOptions Volume3.35%WAYWaystar$24.70+0.2%Moderate Buy$34.67 40.4%244.4559 of 5 stars3.16%ISRGIntuitive Surgical$405.18+1.4%Moderate Buy$508.68 25.5%314.2813 of 5 stars3.08%DXCMDexCom$86.62-1.0%Moderate Buy$89.08 2.8%253.3607 of 5 stars3.08%OSCROscar Health$29.65+2.7%Hold$33.90 14.4%134.529 of 5 starsInsider Trade2.62%PRVAPrivia Health Group$19.71+1.7%Moderate Buy$31.00 57.3%144.6578 of 5 stars2.00%ALHCAlignment Healthcare$8.21+7.0%Moderate Buy$23.60 187.5%114.4249 of 5 starsAnalyst Upgrade1.80%PRCTPROCEPT BioRobotics$17.20-1.7%Hold$25.09 45.9%153.6472 of 5 stars1.75%INSPInspire Medical Systems$70.48+2.4%Hold$66.50 -5.6%192.566 of 5 starsAnalyst Downgrade1.47%TDOCTeladoc Health$6.10-0.7%Hold$7.54 23.6%163.1563 of 5 starsNews Coverage1.36%NVCRNovoCure$15.84-2.2%Hold$21.20 33.8%72.35 of 5 stars This page (NASDAQ:EDOC) was last updated on 9/26/2026 by MarketBeat.com Staff. From Our PartnersA letter from Shannon StansberryPorter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...Porter & Company | SponsoredCODE RED: AI Meltdown Imminent?After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...Paradigm Press | SponsoredI'm giving you a space stock today. Free.On December 8th, $600 billion in frozen SpaceX stock comes loose. Dylan Jovine says one simple purchase in any...Behind the Markets | Sponsored6 Elon Musk companies. The 1 FREE investor roadmap to them all.Elon Musk owns six companies, but most investors can only access four. Tesla, SpaceX, xAI, and X are public an...Zacks | Sponsored"How Much Can I Actually Spend Each Year With $2.5M Saved?"Having $2.5 million saved puts you ahead of most Americans, but how long it lasts depends on the decisions you...SmartAsset | SponsoredBank of America: 'Digital Dollar Inevitable'Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...Decentralized Masters | SponsoredHere’s Why Trump Won’t End The Iran WarTrump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. O...Banyan Hill Publishing | SponsoredThe No. 1 move you need to make before Musk’s “Starphone” goes mainstreamTech forecaster Josh Baylin, who briefed Congress on the iPhone years before its release, says Elon Musk is bu...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Global X Telemedicine & Digital Health ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Global X Telemedicine & Digital Health ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.